Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports
Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated…
TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting
TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or…
New study results support use of DiviTum ® for evaluation of pancreatic cancer
In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer are published in the Pancreas…
Arcus Biosciences secures funding to advance clinical programs for AB928
Clinical-stage biotechnology company Arcus Biosciences has completed a $107m series C financing, bringing the total equity capital to around $227m.…
Summit completes initial dosing trials on Duchenne muscular dystrophy drug
Summit Therapeutics has completed the half-way stage of dosing of its Duchenne Muscular Dystrophy (DMD) candidate ezutromid in a 48-week…
Results of the Randomized, Double-Blind, Placebo-Controlled, Phase III HERCULES study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura to be presented at he 59th Annual Meeting of the American Society of Hematology
Ablynx NV [Euronext Brussels and Nasdaq: ABLX] has announced that results from its Phase III HERCULES study of caplacizumab have been selected…
Khondrion Presents Phase II KHENERGY Trial Data
Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, today announced results from its KHENERGY…
First Ever Effective Intervention Against Dementia Shown in Large Study
Researchers just published the first randomized controlled trial ever to show an intervention effective at lowering the risk of dementia.…
Quanticate launches statistical monitoring services following the ICH GCP E6(R2) addendum
Quanticate, a data-focused clinical research organisation (CRO), has launched its centralised statistical monitoring service (https://www.quanticate.com/centralized-statistical-monitoring) as an extension of its…